Neuronoff, Inc., a clinical-stage neuromodulation company, today announced the first patient implant in a Department of ...
The first patient has been implanted in a Defense Department-funded clinical trial evaluating Neuronoff’s Injectrode device for the treatment of neurogenic bladder in people with spinal cord injury.
The Intibia Pivotal RCT is the first to compare quality-of-life outcomes among patients with urge urinary incontinence implanted with a tibial neurostimulator at therapeutic (intervention) or ...
MOUNT PLEASANT, S.C. (WCSC) — A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the lives of patients. A Lowcountry doctor has ...
Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
Overactive bladder (OAB) is defined as urinary urgency, with or without urge incontinence, often with frequency and nocturia. Initial therapy of OAB often includes anticholinergics and behavioral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results